![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PCDH17 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PCDH17 mRNA | CTD | PMID:22206623 | PCDH17 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of PCDH17 mRNA | CTD | PMID:30723492 | PCDH17 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of PCDH17 mRNA | CTD | PMID:29097150 | PCDH17 | Human | 17beta-estradiol | multiple interactions | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA | CTD | PMID:32741896 | PCDH17 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA | CTD | PMID:32741896 | PCDH17 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:21394737 | PCDH17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCDH17 mRNA | CTD | PMID:21570461 | PCDH17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PCDH17 mRNA | CTD | PMID:33387578 | PCDH17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCDH17 mRNA | CTD | PMID:32109520 | PCDH17 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | PCDH17 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Pcdh17 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | PCDH17 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of PCDH17 mRNA | CTD | PMID:30071829 | PCDH17 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PCDH17 mRNA | CTD | PMID:24780913 and PMID:30047161 | PCDH17 | Human | acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PCDH17 mRNA | CTD | PMID:11906190 | PCDH17 | Human | acrylamide | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of PCDH17 mRNA | CTD | PMID:28959563 | PCDH17 | Human | aflatoxin B1 | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of PCDH17 mRNA | CTD | PMID:23630614 | PCDH17 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PCDH17 gene | CTD | PMID:27153756 | PCDH17 | Human | aldehydo-D-glucose | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Glucose results in increased expression of PCDH17 mRNA | CTD | PMID:33448797 | PCDH17 | Human | aldehydo-D-glucose | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] | CTD | PMID:33448797 | PCDH17 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PCDH17 mRNA | CTD | PMID:21934132 and PMID:23724009 | PCDH17 | Human | amitrole | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of PCDH17 mRNA | CTD | PMID:30047161 | PCDH17 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of PCDH17 mRNA | CTD | PMID:24449571 | PCDH17 | Human | arsane | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Arsenic results in decreased expression of PCDH17 mRNA | CTD | PMID:19654921 | PCDH17 | Human | arsenic atom | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Arsenic results in decreased expression of PCDH17 mRNA | CTD | PMID:19654921 | PCDH17 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of PCDH17 promoter | CTD | PMID:23974009 | PCDH17 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein] | CTD | PMID:26598702 | PCDH17 | Human | astemizole | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Astemizole results in decreased expression of PCDH17 mRNA | CTD | PMID:20221588 | PCDH17 | Human | benzo[a]pyrene | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PCDH17 mRNA | CTD | PMID:21569818 and PMID:22228805 | PCDH17 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PCDH17 promoter | CTD | PMID:27901495 | PCDH17 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PCDH17 5' UTR | CTD | PMID:27901495 | PCDH17 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PCDH17 exon | CTD | PMID:27901495 | PCDH17 | Human | benzo[a]pyrene | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | PCDH17 | Human | benzo[a]pyrene | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PCDH17 mRNA | CTD | PMID:21964900 more ... | PCDH17 | Human | benzo[b]fluoranthene | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of PCDH17 mRNA | CTD | PMID:26377693 | PCDH17 | Human | benzo[b]fluoranthene | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | PCDH17 | Human | bisphenol A | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of PCDH17 mRNA | CTD | PMID:26063408 | PCDH17 | Human | bisphenol A | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PCDH17 mRNA | CTD | PMID:35479511 and PMID:35598803 | PCDH17 | Human | bisphenol A | decreases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PCDH17 mRNA | CTD | PMID:30816183 | PCDH17 | Human | bisphenol A | affects expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of PCDH17 mRNA | CTD | PMID:25181051 | PCDH17 | Human | bisphenol F | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PCDH17 mRNA | CTD | PMID:38685157 | PCDH17 | Human | C60 fullerene | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of PCDH17 mRNA | CTD | PMID:19167457 | PCDH17 | Human | cadmium dichloride | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of PCDH17 mRNA | CTD | PMID:25993096 | PCDH17 | Human | carbon nanotube | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of PCDH17 mRNA | CTD | PMID:25554681 | PCDH17 | Human | carbon nanotube | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of PCDH17 mRNA | CTD | PMID:25554681 and PMID:25620056 | PCDH17 | Human | chloroprene | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of PCDH17 mRNA | CTD | PMID:23125180 | PCDH17 | Human | chrysene | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | PCDH17 | Human | clobetasol | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of PCDH17 mRNA | CTD | PMID:27462272 | PCDH17 | Human | copper atom | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of PCDH17 mRNA | CTD | PMID:26033743 | PCDH17 | Human | copper(0) | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of PCDH17 mRNA | CTD | PMID:26033743 | PCDH17 | Human | D-glucose | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] | CTD | PMID:33448797 | PCDH17 | Human | D-glucose | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Glucose results in increased expression of PCDH17 mRNA | CTD | PMID:33448797 | PCDH17 | Human | decabromodiphenyl ether | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in increased expression of PCDH17 mRNA | CTD | PMID:23640034 | PCDH17 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein] | CTD | PMID:26598702 | PCDH17 | Human | dibenz[a,h]anthracene | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | PCDH17 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | PCDH17 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PCDH17 mRNA | CTD | PMID:29803840 | PCDH17 | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of PCDH17 mRNA | CTD | PMID:27188386 | PCDH17 | Human | ethanol | affects splicing | ISO | Pcdh17 (Mus musculus) | 6480464 | Ethanol affects the splicing of PCDH17 mRNA | CTD | PMID:30319688 | PCDH17 | Human | ethanol | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Ethanol results in increased expression of PCDH17 mRNA | CTD | PMID:30319688 | PCDH17 | Human | fucoxanthin | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] | CTD | PMID:33448797 | PCDH17 | Human | fulvestrant | decreases methylation | EXP | | 6480464 | Fulvestrant results in decreased methylation of PCDH17 gene | CTD | PMID:31601247 | PCDH17 | Human | genistein | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Genistein results in increased expression of PCDH17 mRNA | CTD | PMID:32186404 | PCDH17 | Human | gentamycin | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PCDH17 mRNA | CTD | PMID:33387578 | PCDH17 | Human | glucose | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Glucose results in increased expression of PCDH17 mRNA | CTD | PMID:33448797 | PCDH17 | Human | glucose | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] | CTD | PMID:33448797 | PCDH17 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of PCDH17 mRNA | CTD | PMID:35811015 | PCDH17 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | PCDH17 | Human | medroxyprogesterone acetate | decreases expression | EXP | | 6480464 | Medroxyprogesterone Acetate results in decreased expression of PCDH17 mRNA | CTD | PMID:20843944 | PCDH17 | Human | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of PCDH17 mRNA | CTD | PMID:26272509 | PCDH17 | Human | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | PCDH17 | Human | methimazole | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of PCDH17 mRNA | CTD | PMID:30047161 | PCDH17 | Human | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of PCDH17 mRNA | CTD | PMID:31629900 | PCDH17 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of PCDH17 mRNA | CTD | PMID:28001369 | PCDH17 | Human | miconazole | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Miconazole results in decreased expression of PCDH17 mRNA | CTD | PMID:27462272 | PCDH17 | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PCDH17 mRNA | CTD | PMID:24810058 | PCDH17 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of PCDH17 mRNA | CTD | PMID:28801915 | PCDH17 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | PCDH17 | Human | N-nitrosodiethylamine | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | PCDH17 | Human | ozone | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDH17 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDH17 mRNA | CTD | PMID:34911549 | PCDH17 | Human | paracetamol | affects expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PCDH17 mRNA | CTD | PMID:17562736 | PCDH17 | Human | paracetamol | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of PCDH17 mRNA | CTD | PMID:33387578 | PCDH17 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PCDH17 mRNA | CTD | PMID:36331819 | PCDH17 | Human | phenobarbital | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | PCDH17 | Human | pirinixic acid | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of PCDH17 mRNA | CTD | PMID:18301758 and PMID:23811191 | PCDH17 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of PCDH17 mRNA | CTD | PMID:22714537 | PCDH17 | Human | propiconazole | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | propiconazole results in increased expression of PCDH17 mRNA | CTD | PMID:30047161 | PCDH17 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of PCDH17 mRNA | CTD | PMID:29955902 | PCDH17 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | PCDH17 | Human | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of PCDH17 mRNA | CTD | PMID:35811015 | PCDH17 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | PCDH17 | Human | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of PCDH17 gene | CTD | PMID:28589171 | PCDH17 | Human | sodium arsenite | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PCDH17 mRNA | CTD | PMID:37682722 | PCDH17 | Human | sodium fluoride | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of PCDH17 mRNA | CTD | PMID:27862939 | PCDH17 | Human | sulfadimethoxine | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of PCDH17 mRNA | CTD | PMID:30047161 | PCDH17 | Human | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of PCDH17 mRNA | CTD | PMID:11906190 | PCDH17 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of PCDH17 mRNA | CTD | PMID:31758290 | PCDH17 | Human | testosterone | multiple interactions | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA | CTD | PMID:32741896 | PCDH17 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of PCDH17 mRNA | CTD | PMID:17440010 | PCDH17 | Human | tetraphene | multiple interactions | ISO | Pcdh17 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | PCDH17 | Human | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of PCDH17 mRNA | CTD | PMID:19695317 | PCDH17 | Human | titanium dioxide | decreases methylation | ISO | Pcdh17 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PCDH17 gene | CTD | PMID:35295148 | PCDH17 | Human | titanium dioxide | increases methylation | ISO | Pcdh17 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of PCDH17 promoter | CTD | PMID:35295148 | PCDH17 | Human | titanium dioxide | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of PCDH17 mRNA | CTD | PMID:23557971 | PCDH17 | Human | trichloroethene | increases expression | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of PCDH17 mRNA | CTD | PMID:33387578 | PCDH17 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of PCDH17 mRNA | CTD | PMID:24935251 | PCDH17 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of PCDH17 mRNA | CTD | PMID:24935251 | PCDH17 | Human | trimellitic anhydride | decreases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of PCDH17 mRNA | CTD | PMID:19042947 | PCDH17 | Human | triptonide | increases expression | ISO | Pcdh17 (Mus musculus) | 6480464 | triptonide results in increased expression of PCDH17 mRNA | CTD | PMID:33045310 | PCDH17 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PCDH17 mRNA | CTD | PMID:24383497 | PCDH17 | Human | valproic acid | affects splicing | ISO | Pcdh17 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of PCDH17 mRNA | CTD | PMID:29427782 | PCDH17 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PCDH17 mRNA | CTD | PMID:19101580 more ... | PCDH17 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PCDH17 mRNA | CTD | PMID:25979313 | PCDH17 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of PCDH17 mRNA | CTD | PMID:24714768 | |